Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
BioNTech
Biotech
BioNTech, Genentech cancel ph. 2 test of personalized cancer vax
An independent safety board recommended the trial be terminated early after more deaths were observed in patients given the customized mRNA vaccine.
Darren Incorvaia
Aug 28, 2026 1:50pm
BioNTech brings in Sobi CEO—Chutes & Ladders
Aug 7, 2026 8:30am
After 5-month wait, BioNTech reveals Sobi CEO will take top job
Aug 3, 2026 7:35am
Fierce Pharma
At ASCO, China biotech industry cements its coming of age
Jun 3, 2026 8:50am
ASCO: BioNTech/BMS, Pfizer split on bispecific approach in NSCLC
May 30, 2026 3:30pm
AACR: Merck unveils PD-1xVEGF bispecific data in NSCLC
Apr 17, 2026 3:00pm
